Search
for
Sort by
Research 211–240 of 1000+
- Impact of nutrition and exercise on polycystic ovarian syndrome
- A PROSPECTIVE OBSERVATIONAL STUDY ON EVALUATION OF COMPLICATIONS IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
- Acne-Associated Syndromes
- Polycystic Ovary Syndrome
- POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW
- Controversies in Polycystic Ovary Syndrome
- Metabolic Aspects of Polycystic Ovary Syndrome
- Metabolic Aspects of Polycystic Ovary Syndrome
- The influence of non-esterified fatty acids (NEFA) on the ovarian production of androgens in a context of in vitro fertilisation (IVF) – preliminary results
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- Early onset androgenic alopecia as the male phenotypic equivalent of polycystic ovarian syndrome is associated in high oxidative stress
- Actualités du SOPK
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Developmental origin of polycystic ovary syndrome - a hypothesis
- Obesity and the skin: Skin physiology and skin manifestations of obesity
- Potential role and therapeutic interests of myo-inositol in metabolic diseases
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- Prevalence of polycystic ovary syndrome in women in China: a large community-based study
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- Metabolic risk in PCOS: phenotype and adiposity impact
- Endothelial Dysfunction in PCOS: Role of Obesity and Adipose Hormones
- Global Adiposity Rather Than Abnormal Regional Fat Distribution Characterizes Women with Polycystic Ovary Syndrome
- Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Obesity and polycystic ovary syndrome
- Hair Loss in Women
- Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial